Fox Chase Cancer Center is a clinical research site located in Rockledge, Pennsylvania, United States 19046.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Fox Chase Cancer Center has participated in 8 clinical trials.
Therapeutic areas: EGFR Inhibitor-associated Rash, Advanced Solid Tumors, Lymphoma.
Sponsors: Spectrum Pharmaceuticals, Inc, Millennium Pharmaceuticals, Inc., National Cancer Institute (NCI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Rockledge
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Fox Chase Cancer Center has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fox Chase Cancer Center has 8 clinical trials on record. Their work covers EGFR Inhibitor-associated Rash, Advanced Solid Tumors, Lymphoma.
Fox Chase Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.